Augmedix to Attend the Benchmark 2022 Discovery One-on-One Investor Conference
24 November 2022 - 08:05AM
Augmedix Inc. (Nasdaq:
AUGX), a healthcare technology company that delivers
industry-leading, ambient medical documentation and data solutions,
today announced the Company will participate in Benchmark Company’s
11th Annual Discovery One-on-One Investor Conference to be held
Thursday, December 1, 2022 at the New York Athletic Club in New
York City. Augmedix’s management will participate in one-on-one
meetings with institutional analysts and investors throughout the
day.
The conference offers emerging growth and dynamic
publicly traded companies access to institutional investors and
analysts in a one-on-one format.
To schedule a one-on-one meeting with Augmedix
Inc., you may submit your request online via the link provided upon
registration. To register for the conference, please visit
Benchmark’s event page at:
https://www.benchmarkcompany.com/news-events/upcoming-events/the-11th-annual-discovery-one-on-one-investor-conference.
About AugmedixAugmedix (Nasdaq:
AUGX) delivers industry-leading, ambient medical documentation and
data solutions to healthcare systems, physician practices,
hospitals, and telemedicine practitioners.
Augmedix is on a mission to help clinicians and
patients form a human connection at the point of care without the
intrusion of technology. Augmedix’s solutions extract data from
natural physician-patient conversations and convert it to medical
notes in real time, which are seamlessly transferred to the EHR. To
achieve this, the company’s Ambient Automation Platform uses
Automated Speech Recognition and Natural Language Processing,
supported by medical documentation specialists.
Leveraging this platform, Augmedix’s solutions
relieve clinicians of administrative burden, in turn, reducing
burnout and increasing both clinician and patient satisfaction.
Augmedix is also leading the revolution in leveraging point-of-care
data by making connections between millions of physician-patient
interactions and analyzing them to deliver actionable insights that
elevate patient care.
Augmedix is headquartered in San Francisco, CA,
with offices around the world. To learn more, visit
www.augmedix.com.
Investors:Ji-Yon YiGilmartin
Groupinvestors@augmedix.com
Media:Kaila GrafemanAugmedixpr@augmedix.com
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Feb 2024 to Mar 2024
Augmedix (NASDAQ:AUGX)
Historical Stock Chart
From Mar 2023 to Mar 2024